This inventor holds 1 USPTO granted patent. Top assignee: Barr Laboratories, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Lianli Li - Innovator in Pharmaceutical Dosage Forms
Introduction
Lianli Li is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on enhancing the delivery and effectiveness of medications.
Latest Patents
Lianli Li holds a patent for "Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same." This invention is directed towards creating non-effervescent, orally disintegrating dosage forms that contain free base clozapine. These dosage forms are designed to be substantially free of acids, water-soluble polymers, taste-masking polymers, and coatings, thereby improving the patient experience and medication efficacy.
Career Highlights
Lianli Li is currently employed at Barr Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His work has led to advancements that benefit both healthcare providers and patients alike.
Collaborations
Some of his notable coworkers include Salah Uddin Ahmed and Tahseen A Chowdhury. Their collaborative efforts contribute to the ongoing success and innovation at Barr Laboratories, Inc.
Conclusion
Lianli Li's contributions to pharmaceutical dosage forms exemplify the impact of innovation in healthcare. His patent and ongoing work at Barr Laboratories, Inc. highlight the importance of developing effective medication delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile